AVTR
Avantor, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #519
- Final score
- 49.57
- Years on list
- 6
↗ Climbed 144 since 2020
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 144 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 439 since 2022
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | AVTR | TEM | NTRA |
|---|---|---|---|
| Climate Change | 57.4 | 50.0 | 57.1 |
| Employee Relations | 45.1 | 50.0 | 40.3 |
| Environment | 46.5 | 50.0 | 55.8 |
| Stakeholders & Society | 55.9 | 50.0 | 35.1 |
| Human Rights | 43.1 | 50.0 | 51.9 |
| Governance | 45.2 | 49.2 | 45.3 |
| Performance Rating | 49.8 | 50.0 | 61.7 |